Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)
- Status
- COMPLETED
- Phase
- PHASE3
A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients
- Status
- COMPLETED
- Phase
- PHASE1
PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Comparing the Pharmacokinetics, Safety and Tolerability of NVA237 in Renal Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Post Hematopoietic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE4
Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I Study of LFA102 in Japanese Patients
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate in Patients With Persistent Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Trial Evaluating Nilotinib as Treatment for Newly Diagnosed CML Patients in Accelerated Phase.
- Status
- WITHDRAWN
- Phase
- PHASE4
Efficacy, Safety and Tolerability of the Co-administration of NVA237 Plus Indacaterol Once Daily Versus Indacaterol Once Daily in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
Human Urine Sample Collection for Alport Nephropathy Biomarker Studies
- Status
- TERMINATED
- Phase
- N/A
Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE1